Genomic Integration and Molecular Dysregulation in Aggressive Stage IV Bladder Cancer Following COVID-19 mRNA Vaccination

Abstract: Background: Bladder cancer is rare in young women, and advanced presentations are exceptionally uncommon. We report a de-identified case of a previously healthy 31-year-old female who developed rapidly progressive stage IV bladder cancer within 12 months of completing a three-dose Moderna…